Some Member States (Belgium, Denmark, France, Finland, Italy, Poland, Slovenia and Spain) reported increase in the notifications for gene therapy clinical trials, while in Germany the number has decreased.
Xi Stati Membri (il-Belġju, id-Danimarka, Franza, il-Finlandja, l-Italja, il-Polonja, is-Slovenja u Spanja) irrapportaw żieda fin-notifiki għal provi kliniċi tat-terapija tal-ġeni, filwaqt li fil-Ġermanja n-numru naqas.